Shares Outstanding: 147.04M
The shares outstanding is 147.04M. It is below its 12-month average by 0.02% (147.07M).
RMD Shares Outstanding
Reported quarterly weighted average share count; no daily interpolation.
RMD Average Shares Outstanding Chart
RMD Current vs Average Shares Outstanding Chart
RMD Shares Outstanding Metrics
SHARES OUTSTANDING
147.04M
SHARES OUTSTANDING AVG TTM
147.07M
SHARES OUTSTANDING AVG 3Y
147.35M
SHARES OUTSTANDING AVG 5Y
147.22M
SHARES OUTSTANDING AVG 10Y
145.61M
SHARES OUTSTANDING AVG 15Y
145.33M
SHARES OUTSTANDING AVG 20Y
148.06M
CURRENT VS TTM AVG
-0.02%
CURRENT VS 3Y AVG
-0.21%
CURRENT VS 5Y AVG
-0.13%
CURRENT VS 10Y AVG
+0.98%
CURRENT VS 15Y AVG
+1.17%
CURRENT VS 20Y AVG
-0.69%
Share Structure
Shares Outstanding
146.72M
Float Shares
N/A
Stock Price
$198.60
Market Cap
$28.8B
Quarterly Shares Outstanding History
| Period | Weighted Average Shares | QoQ Change |
|---|---|---|
| Q3 2026 | 147.04M | +0.00% |
| Q2 2025 | 147.04M | +0.00% |
| Q1 2025 | 147.04M | +0.00% |
| Q4 2025 | 147.04M | -0.12% |
| Q3 2025 | 147.22M | -0.26% |
| Q2 2024 | 147.60M | +0.00% |
| Q1 2024 | 147.60M | +0.04% |
| Q4 2024 | 147.53M | +0.06% |
| Q3 2024 | 147.45M | -0.06% |
| Q2 2023 | 147.54M | +0.04% |
| Q1 2023 | 147.49M | -0.05% |
| Q4 2023 | 147.55M | +0.11% |
| Q3 2023 | 147.40M | -0.01% |
| Q2 2022 | 147.41M | +0.18% |
| Q1 2022 | 147.13M | +0.09% |
| Q4 2022 | 147.00M | +0.03% |
| Q3 2022 | 146.96M | -0.05% |
| Q2 2021 | 147.04M | +0.12% |
| Q1 2021 | 146.86M | +0.22% |
| Q4 2021 | 146.54M | +0.71% |
| Q3 2021 | 145.51M | -0.62% |
| Q2 2020 | 146.42M | +0.22% |
| Q1 2020 | 146.10M | +0.16% |
| Q4 2020 | 145.87M | +0.13% |
| Q3 2020 | 145.68M | +0.07% |
| Q2 2019 | 145.57M | +0.33% |
| Q1 2019 | 145.10M | +0.28% |
| Q4 2019 | 144.69M | +0.25% |
| Q3 2019 | 144.33M | -0.01% |
| Q2 2018 | 144.35M | +0.22% |
| Q1 2018 | 144.03M | +0.02% |
| Q4 2018 | 144.00M | +0.01% |
| Q3 2018 | 143.99M | +0.09% |
| Q2 2017 | 143.85M | +0.26% |
| Q1 2017 | 143.48M | +0.25% |
| Q4 2017 | 143.12M | +0.28% |
| Q3 2017 | 142.72M | +0.44% |
| Q2 2016 | 142.10M | +0.00% |
| Q1 2016 | 142.09M | +0.31% |
| Q4 2016 | 141.65M | +0.44% |
| Q3 2016 | 141.04M | -0.08% |
| Q2 2015 | 141.15M | -0.56% |
| Q1 2015 | 141.95M | -0.53% |
| Q4 2015 | 142.70M | -0.08% |
| Q3 2015 | 142.81M | +0.43% |
| Q2 2014 | 142.20M | -0.34% |
| Q1 2014 | 142.68M | -0.28% |
| Q4 2014 | 143.09M | -0.20% |
| Q3 2014 | 143.38M | -1.35% |
| Q2 2013 | 145.34M | -0.08% |
| Q1 2013 | 145.46M | -0.45% |
| Q4 2013 | 146.12M | -0.36% |
| Q3 2013 | 146.64M | -0.03% |
| Q2 2012 | 146.69M | +0.43% |
| Q1 2012 | 146.06M | -0.03% |
| Q4 2012 | 146.10M | -0.72% |
| Q3 2012 | 147.16M | -1.58% |
| Q2 2011 | 149.51M | -2.94% |
| Q1 2011 | 154.05M | -1.70% |
| Q4 2011 | 156.72M | -0.40% |
| Q3 2011 | 157.36M | -0.15% |
| Q2 2010 | 157.59M | +0.54% |
| Q1 2010 | 156.75M | +3.48% |
| Q4 2010 | 151.47M | -2.69% |
| Q3 2010 | 155.66M | +1.03% |
| Q2 2009 | 154.07M | +0.35% |
| Q1 2009 | 153.52M | +1.81% |
| Q4 2009 | 150.79M | -2.41% |
| Q3 2009 | 154.51M | -0.13% |
| Q2 2008 | 154.72M | +0.23% |
| Q1 2008 | 154.36M | +2.07% |
| Q4 2008 | 151.23M | -3.81% |
| Q3 2008 | 157.21M | +0.01% |
| Q2 2007 | 157.20M | -0.43% |
| Q1 2007 | 157.88M | +1.77% |
| Q4 2007 | 155.14M | +0.69% |
| Q3 2007 | 154.07M | -1.42% |
| Q2 2006 | 156.28M | +0.11% |
| Q1 2006 | 156.11M | +2.84% |
| Q4 2006 | 151.79M | -1.95% |
| Q3 2006 | 154.81M | +0.29% |
| Q2 2005 | 154.37M | +1.19% |
| Q1 2005 | 152.55M | +8.42% |
| Q4 2005 | 140.70M | -6.81% |
| Q3 2005 | 150.98M | +1.73% |
| Q2 2004 | 148.41M | +5.23% |
| Q1 2004 | 141.03M | +4.04% |
| Q4 2004 | 135.55M | -3.33% |
| Q3 2004 | 140.22M | +0.03% |
| Q2 2003 | 140.18M | -0.13% |
| Q1 2003 | 140.36M | +4.28% |
| Q4 2003 | 134.60M | -2.65% |
| Q3 2003 | 138.26M | +0.63% |
| Q2 2002 | 137.38M | +0.66% |
| Q1 2002 | 136.48M | +3.77% |
| Q4 2002 | 131.53M | - |
Relationship: Market Cap = Shares Outstanding × Stock Price
Key concepts:
- Float shares: Shares available for public trading
- Dilution: When new shares are issued, existing shareholders own less
- Buybacks: Reduce share count, increasing EPS and ownership stake
- Stock splits: Increase share count but don't change market cap
Shares Outstanding Formula & Definition
Shares Outstanding represents the reported weighted average share count used for per-share metrics. Changes in share count affect EPS and ownership dilution.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
Shares Outstanding FAQ
- What is the shares outstanding for ResMed Inc. (RMD)?
- The shares outstanding for RMD stock is 147.04M.
- What is the TTM average shares outstanding for ResMed Inc. (RMD)?
- The TTM average shares outstanding for RMD stock is 147.07M.
- What is the 3Y average shares outstanding for ResMed Inc. (RMD)?
- The 3Y average shares outstanding for RMD stock is 147.35M.
- What is the 5Y average shares outstanding for ResMed Inc. (RMD)?
- The 5Y average shares outstanding for RMD stock is 147.22M.
- What is the 10Y average shares outstanding for ResMed Inc. (RMD)?
- The 10Y average shares outstanding for RMD stock is 145.61M.
- What is the 15Y average shares outstanding for ResMed Inc. (RMD)?
- The 15Y average shares outstanding for RMD stock is 145.33M.
- What is the 20Y average shares outstanding for ResMed Inc. (RMD)?
- The 20Y average shares outstanding for RMD stock is 148.06M.
RMD Shares Outstanding History
| DATE | SHARES OUTSTANDING |
|---|---|
| 2026-03-31 | 147.04M |
| 2025-12-31 | 147.04M |
| 2025-09-30 | 147.04M |
| 2025-06-30 | 147.04M |
| 2025-03-31 | 147.22M |
| 2024-12-31 | 147.60M |
| 2024-09-30 | 147.60M |
| 2024-06-30 | 147.53M |
| 2024-03-31 | 147.45M |
| 2023-12-31 | 147.54M |
| 2023-09-30 | 147.49M |
| 2023-06-30 | 147.55M |
| 2023-03-31 | 147.40M |
| 2022-12-31 | 147.41M |
| 2022-09-30 | 147.13M |
| 2022-06-30 | 147.00M |
| 2022-03-31 | 146.96M |
| 2021-12-31 | 147.04M |
| 2021-09-30 | 146.86M |
| 2021-06-30 | 146.54M |
| 2021-03-31 | 145.51M |
| 2020-12-31 | 146.42M |
| 2020-09-30 | 146.10M |
| 2020-06-30 | 145.87M |
| 2020-03-31 | 145.68M |
| 2019-12-31 | 145.57M |
| 2019-09-30 | 145.10M |
| 2019-06-30 | 144.69M |
| 2019-03-31 | 144.33M |
| 2018-12-31 | 144.35M |
| 2018-09-30 | 144.03M |
| 2018-06-30 | 144.00M |
| 2018-03-31 | 143.99M |
| 2017-12-31 | 143.85M |
| 2017-09-30 | 143.48M |
| 2017-06-30 | 143.12M |
| 2017-03-31 | 142.72M |
| 2016-12-31 | 142.10M |
| 2016-09-30 | 142.09M |
| 2016-06-30 | 141.65M |
| 2016-03-31 | 141.04M |
| 2015-12-31 | 141.15M |
| 2015-09-30 | 141.95M |
| 2015-06-30 | 142.70M |
| 2015-03-31 | 142.81M |
| 2014-12-31 | 142.20M |
| 2014-09-30 | 142.68M |
| 2014-06-30 | 143.09M |
| 2014-03-31 | 143.38M |
| 2013-12-31 | 145.34M |
| 2013-09-30 | 145.46M |
| 2013-06-30 | 146.12M |
| 2013-03-31 | 146.64M |
| 2012-12-31 | 146.69M |
| 2012-09-30 | 146.06M |
| 2012-06-30 | 146.10M |
| 2012-03-31 | 147.16M |
| 2011-12-31 | 149.51M |
| 2011-09-30 | 154.05M |
| 2011-06-30 | 156.72M |
| 2011-03-31 | 157.36M |
| 2010-12-31 | 157.59M |
| 2010-09-30 | 156.75M |
| 2010-06-30 | 151.47M |
| 2010-03-31 | 155.66M |
| 2009-12-31 | 154.07M |
| 2009-09-30 | 153.52M |
| 2009-06-30 | 150.79M |
| 2009-03-31 | 154.51M |
| 2008-12-31 | 154.72M |
| 2008-09-30 | 154.36M |
| 2008-06-30 | 151.23M |
| 2008-03-31 | 157.21M |
| 2007-12-31 | 157.20M |
| 2007-09-30 | 157.88M |
| 2007-06-30 | 155.14M |
| 2007-03-31 | 154.07M |
| 2006-12-31 | 156.28M |
| 2006-09-30 | 156.11M |
| 2006-06-30 | 151.79M |
| 2006-03-31 | 154.81M |
| 2005-12-31 | 154.37M |
| 2005-09-30 | 152.55M |
| 2005-06-30 | 140.70M |
| 2005-03-31 | 150.98M |
| 2004-12-31 | 148.41M |
| 2004-09-30 | 141.03M |
| 2004-06-30 | 135.55M |
| 2004-03-31 | 140.22M |
| 2003-12-31 | 140.18M |
| 2003-09-30 | 140.36M |
| 2003-06-30 | 134.60M |
| 2003-03-31 | 138.26M |
| 2002-12-31 | 137.38M |
| 2002-09-30 | 136.48M |
| 2002-06-30 | 131.53M |
Related Metrics
About ResMed Inc.
ResMed Inc. is a leading global medical technology enterprise engaged in the creation, production, distribution, and marketing of healthcare devices and connected digital solutions. The company operates through two primary segments: Sleep and Respiratory Care, and Software as a Service. Its extensive product range addresses a variety of respiratory disorders, encompassing advanced medical and consumer technologies, ventilation devices, diagnostic equipment, mask systems for both clinical and personal use, headgear, and related accessories, alongside dental devices. ResMed also provides sophisticated cloud-based informatics to enhance patient management and operational efficiency. Notable software offerings in its respiratory portfolio include AirView, for remote device monitoring and setting adjustments; myAir, a personalized application designed to support sleep apnea patients with education and troubleshooting for better engagement and adherence; and U-Sleep, a compliance tracking platform for home medical equipment providers. Complementing these are connectivity modules and Propeller solutions. Furthermore, ResMed offers a robust suite of out-of-hospital software. This includes Brightree, a business management platform for various home care service providers (e.g., HME, pharmacy, infusion, orthotics, prosthetics); MatrixCare, providing care management for senior living, skilled nursing, and hospice organizations; and HEALTHCAREfirst, which supplies electronic health records, billing, coding services, and analytics for home health and hospice agencies. ResMed distributes its offerings primarily to sleep clinics, home healthcare dealers, and hospitals via a global network of distributors and a direct sales force, serving approximately 140 countries. Founded in 1989, the company's headquarters are located in San Diego, California.
- Sector
- Healthcare
- Industry
- Medical - Devices
- CEO
- Michael J. Farrell